ArticleJournal of applied clinical medical physics2026
Automatic adaptive radiotherapy triggering based on CBCT using deep learning for esophageal cancer underwent volumetric modulated arc therapy.
Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundEsophageal cancer (EC) is a highly fatal malignancy for which radiotherapy plays a critical role in treatment. However, anatomical changes during radiotherapy can lead to increased doses to surrounding organs at risk (OARs). Adaptive radiotherapy (ART) is a strategy that incorporates patient-specific anatomic changes into treatment plan modification to minimize overdose to surrounding healthy tissues. Identifying appropriate triggers with in-room verification imaging is critical to maximize the benefits of ART and prevent additional imaging dose to a certain extent for patients without compromising clinical resources or operations. PURPOSE: To develop an automatic ART triggering procedure by predicting the patient's anatomical changes and their resulted dose-volume metrics differences on OARs using deep learning (DL) based on cone-beam computed tomography (CBCT) to efficiently and effectively balance the benefit and frequency of ART.
methodsA DL network was first trained to automatically segment OARs on the CBCT of 136 EC patients underwent volumetric modulated arc therapy (VMAT). The dose distributions on CBCT with the automatically contoured OARs were predicted with Unet. A set of trigger criteria based on OAR dosimetry deformed form original treatment plan was established to assess replanning necessity. The feasibility and accuracy of automatic segmentation and dose prediction on CBCT were verified with rescan CT (rCT) and CBCT at the same time point.
resultsThe average dices of the automatic segmentation model for the lung, heart, and spinal cord were 0.92, 0.91, and 0.80, respectively. The predicted dose distributions on CBCT were close to mapped dose distributions. The ART trigger decision agreement between rCT and CBCT was 81.8%. CBCT with automatic segmentation OARs achieved an area under curve, accuracy, sensitivity, and specificity of 0.86, 0.82, 1.0, and 0.71 in the triggering of ART for EC patients, respectively.
conclusionAn automatic ART triggering procedure was established based on CBCT directly for EC patients underwent VMAT. It is a feasible and promising ART methods to improve the management of EC patients without additional patients appoints and resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.